{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:49:49Z","timestamp":1787791789382,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejogrb.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T14:18:27Z","timestamp":1484835507000},"page":"334-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?"],"prefix":"10.1016","volume":"210","author":[{"given":"Jessica J.F.","family":"Kram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie M.","family":"Forgie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish S.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.01.022_bib0005","article-title":"Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial [published erratum appears in Am J Obstet Gynecol 2007;197:333]","volume":"196","author":"Sullivan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0010","first-page":"1","article-title":"Births: final data for 2011","volume":"62","author":"Martin","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0015","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000789","article-title":"Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial","volume":"125","author":"Maggio","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"415","key":"10.1016\/j.ejogrb.2017.01.022_bib0020","first-page":"e1","article-title":"Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women","volume":"213","author":"Swank","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0025","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/AOG.0b013e3182238c31","article-title":"American college of obstetricians and gynecologists. use of antibiotics in labor and delivery. practice bulletin No 120","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-0528.2010.02729.x","article-title":"Current debate on the use of antibiotic prophylaxis for caesarean section","volume":"118","author":"Lamont","year":"2011","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0035","first-page":"CD007482","article-title":"Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section","volume":"10","author":"Smaill","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.01.022_bib0040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1701-2163(16)34662-X","article-title":"Antibiotic prophylaxis in obstetric procedures","volume":"32","author":"Van Schalkwyk","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.AOG.0000459870.06491.71","article-title":"American College of Obstetricians and Gynecologists. Gynecologic surgery in the obese woman. Committee Opinion No. 619","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery: american society of health-System pharmacists; infectious disease society of america; surgical infection society; society for healthcare epidemiology of america","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1592\/phco.27.8.1081","article-title":"Antimicrobial dosing considerations in obese adult patients","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0060","first-page":"959","article-title":"Obesity as an independent risk Factor for infectious morbidity in patients who undergo cesarean delivery","volume":"100","author":"Myles","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/AOG.0000000000001211","article-title":"American College of Obstetricians and Gynecologists. Obesity in pregnancy. Practice Bulletin No 156","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/AOG.0b013e31820b95e4","article-title":"Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery","volume":"117","author":"Pevzner","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"541","key":"10.1016\/j.ejogrb.2017.01.022_bib0075","first-page":"e1","article-title":"Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery","volume":"213","author":"Young","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0080","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/AOG.0000000000001064","article-title":"Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women","volume":"126","author":"Ahmadzia","year":"2015","journal-title":"Obst Gynecol"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/sur.2012.040","article-title":"Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug","volume":"14","author":"Stitley","year":"2013","journal-title":"Surg Infect"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jchromb.2016.07.032","article-title":"Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS\/MS): application to a pilot study of obese women undergoing cesarean delivery","volume":"1031","author":"Lillico","year":"2016","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11695-014-1231-0","article-title":"Antibiotic prophylaxis in bariatric surgery with continuous infusion of cefazolin: determination of concentration in adipose tissue","volume":"24","author":"Anlicoara","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0100","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.surg.2004.06.022","article-title":"Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels","volume":"136","author":"Edmiston","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1467-789X.2007.00397.x","article-title":"Maternal obesity and risk of cesarean delivery; a meta-analysis","volume":"8","author":"Chu","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1198\/000313001300339897","article-title":"The abuse of power: the pervasive fallacy of power calculations for data analysis","volume":"55","author":"Hoenig","year":"2001","journal-title":"Am Stat"},{"key":"10.1016\/j.ejogrb.2017.01.022_bib0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1511\/2009.79.310","article-title":"Of beauty, sex and power: too little attention has been paid to the statistical challenges in estimating small effects","volume":"97","author":"Gelman","year":"2009","journal-title":"Am Sci"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517300222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517300222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:00:25Z","timestamp":1779807625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517300222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":23,"alternative-id":["S0301211517300222"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.022","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}